China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves…
WATCHLIST OCT 16 2026 Benzinga PreMarket Gainers (% change and volume) $EVTL $HODO $ZTG $NCPL $TCRT $KOLD $JAGX $SXTC $AIXI $RUBI $UAMY $IRD $AEHL Read our Benzinga Review here: https://t.co/DbZGLBN9ND https://t.co/iYsdtY1rOC
$MNDR looking for follow through tomorrow…through highs today. Type that can go bonkers premarket like $BIYA $SXTC
$SXTC paying all day…nice MNDR another china healthcare at rock bottom. Not many https://t.co/qKCu8jyPI2
I wouldn’t sleep on MNDR after the $BIYA $SXTC madness They turned on ssr yesterday and now back up on air
$SXTC just wicked from $1.80 to $7+ $NCT give us that volume already https://t.co/waoPyFqoXf
stick to the Asian/China plays for now imo…only ones that consistently run hard $SXTC case in point
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2026 | $1.07M | -38.39% | $-6.21M |
| 2025 | $1.74M | -9.73% | $-3.3M |
| 2024 | $1.93M | -2.19% | $-3.1M |
Stock data for SXTC: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics